|
시장보고서
상품코드
1863891
프리필드 시린지 시장 : 소재별, 약제 유형별, 설계별, 제품 유형별, 사용성별, 제조 방법별, 최종사용자별, 지역별Prefilled Syringes Market, By Material, By Drug Type, By Design, By Product Type, By Usability, By Manufacturing Method, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
프리필드 시린지 시장은 2025년에 71억 8,000만 달러로 추정되고, 2032년까지 105억 1,000만 달러에 이를 것으로 예측되며, 2025-2032년 CAGR 5.6%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2024년 | 2025년 시장 규모 : | 71억 8,000만 달러 |
| 실적 데이터 : | 2020-2024년 | 예측 기간 : | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR : | 5.60% | 2032년 가치 예측 | 105억 1,000만 달러 |
프리필드시린지는 주사할 약물이 미리 채워진 일회용 주사기입니다. 제조업체에서 바늘이 부착된 1회용 약품으로, 1회용 약품입니다. 이 주사기는 미리 채워져 있기 때문에 간호사나 환자가 약물을 준비하고 바늘에 흡입할 필요가 없으며, 주사기 안에 적절한 용량이 이미 준비되어 있어 빠른 주사가 가능합니다. 또한, 프리필드시린지는 정밀도가 높기 때문에 더욱 안전하게 사용할 수 있습니다. 일부 프리필드시린지 카트리지는 자가흡입식 주사기에 적합하도록 설계되어 피부를 관통하여 약액을 공급하기 때문에 플런저를 누를 필요가 없습니다. 이를 통해 약액이 원활하게 공급되고 주사가 적절한 깊이에 도달할 수 있도록 보장합니다.
시장 역학
만성 질환의 발생률 증가는 치료 수단으로서 프리필드시린지에 대한 수요를 견인하여 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 미국 질병예방통제센터(CDC)가 2022년 7월에 업데이트한 만성질환 데이터에 따르면, 미국 성인의 약 60%가 만성질환의 영향을 받고 있으며, 40% 이상이 2개 이상의 만성질환을 앓고 있다고 합니다. 암은 전 세계적으로 가장 많은 사람들에게 영향을 미치는 만성질환입니다. 예를 들어, GLOBOCAN 2020 보고서에 따르면, 2020년 전 세계 암 환자 수는 약 19,292,789명입니다. 이 숫자는 2040년까지 28,887,940건으로 증가할 것으로 예측됩니다. 여러 암종은 새로운 약물과 생물학적 제제를 사용하여 치료되고 있으며, 이로 인해 2025-2032년의 예측 기간 동안 프리필드시린지 수요가 증가할 것으로 예측됩니다. 따라서 전 세계적으로 암 사례가 증가함에 따라 예측 기간 동안 프리필드시린지 시장의 성장을 가속할 것으로 예측됩니다.
시장 진출기업들의 제품 포트폴리오 확장을 위한 각종 규제 당국의 승인 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 12월 다국적 제약기업인 Alembic Pharmaceuticals Limited는 미국 식품의약국(FDA)으로부터 1회 투여용 프리필드 주사기용 풀베스트란트 주사제(250 mg/5 mL, 50 mg/mL)에 대한 간소화 신약 신청(ANDA)을 최종 승인받았다고 발표했습니다. ANDA)에 대해 최종 승인을 받았다고 발표했습니다. 플루베스트란트 주사액은 유방암 치료에 사용되는 에스트로겐 수용체 길항제입니다.
본 조사의 주요 특징
- 이 보고서는 2024년을 기준 연도, 2025년부터 2032년까지의 예측 기간 동안 시장 규모와 CAGR(%)을 나타내는 세계 프리필드시린지 시장에 대한 상세한 분석을 제공합니다.
- 본 보고서에서는 다양한 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 이 보고서는 시장 성장 촉진요인 및 저해요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들이 채택한 경쟁 전략에 대한 중요한 통찰력을 제공합니다.
- 이 보고서에서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 프리필드시린지 시장의 주요 업체를 프로파일링합니다.
- 이 보고서는 마케팅 담당자 및 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 보고서는 세계 프리필드시린지 시장의 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 프리필드시린지 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 매력 분석
- 시장 기회
- 제품 발매
- 합병, 인수, 제휴
- 규제 가이드라인과 컴플라이언스
- 주요 발전
- PEST 분석
- 기술 상황
- 서비스 비용 분석
제4장 세계의 프리필드 시린지 시장 : 소재별, 2025-2032년
- 유리
- 플라스틱 및 폴리머
제5장 세계의 프리필드 시린지 시장 : 약제 유형별, 2025-2032년
- 생물학적 제제
- 백신
- 인슐린
- 항응고제
- Flush Saline Syringe
- 기타
제6장 세계의 프리필드 시린지 시장 : 설계별, 2025년-2032년
- Single-chamber
- Dual-chamber
- Multi-chambered
제7장 세계의 프리필드 시린지 시장, 제품 유형별, 2025년-2032년
- Staked in-needle pre-filled syringes
- Needle-free pre-filled syringes
제8장 세계의 프리필드 시린지 시장, 사용성별, 2025년-2032년
- 일회용
- 재이용 가능
제9장 세계의 프리필드 시린지 시장, 제조 방법별, 2025년-2032년
- 자사내 생산
- 상업 판매
제10장 세계의 프리필드 시린지 시장, 최종사용자별, 2025년-2032년
- 병원
- 클리닉
- 외래수술센터(ASC)
- 기타
제11장 세계의 프리필드 시린지 시장, 지역별, 2025년-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙아프리카
- 남아프리카공화국
제12장 경쟁 구도
- Gerresheimer AG
- Becton, Dickinson and Company
- West Pharmaceutical Services, Inc.
- Terumo Corporation
- Nipro Europe Group Companies
- B.Braun SE
- GSK plc.
- Pfizer Inc.
- Bayer AG
- Polymedicure
- Amsino International, Inc.
- Leeford Healthcare Limited
- Torrent Pharmaceuticals Ltd.
- Regeneron Pharmaceuticals Inc.
- Ypsomed AG
- SOL-Millennium
- Stevanato Group S.p.A.
제13장 섹션
- 조사 방법
- 출판사에 대해
Prefilled Syringes Market is estimated to be valued at USD 7.18 Bn in 2025 and is expected to reach USD 10.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 7.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.60% | 2032 Value Projection: | USD 10.51 Bn |
Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.
Market Dynamics
Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period 2025-2032. Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.
The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.
Key features of the study
- This report provides in-depth analysis of the global prefilled syringes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market
Market Segmentation
- Global Prefilled Syringes Market, By Material
- Glass
- Plastic/Polymer
- Global Prefilled Syringes Market, By Drug Type
- Biologics
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
- Vaccines
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
- Insulin
- Anticoagulants
- Flush Saline Syringes
- Others
- Global Prefilled Syringes Market, By Design
- Single-chamber
- Dual-chamber
- Multi-chambered
- Global Prefilled Syringes Market, By Product Type
- Staked in-needle pre-filled syringes
- Needle-free pre-filled syringes
- Global Prefilled Syringes Market, By Usability
- Disposable
- Reusable
- Global Prefilled Syringes Market, By Manufacturing Method
- Captive
- Merchant
- Global Prefilled Syringes Market, By End User
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
- Global Prefilled Syringes Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Gerresheimer AG
- Becton, Dickinson and Company
- West Pharmaceutical Services, Inc.
- Terumo Corporation
- Nipro Europe Group Companies
- B. Braun SE
- Sanofi
- GSK plc.
- Pfizer Inc.
- Bayer AG
- Polymedicure
- Amsino International, Inc.
- Leeford Healthcare Limited
- Torrent Pharmaceuticals Ltd.
- Regeneron Pharmaceuticals Inc.
- Ypsomed AG
- SOL-Millennium
- Stevanato Group S.p.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Material
- Market Snapshot, By Drug Type
- Market Snapshot, By Design
- Market Snapshot, By Product Type
- Market Snapshot, By Usability
- Market Snapshot, By Manufacturing Method
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- Service Cost Analysis
4. Global Prefilled Syringes Market, By Material, 2025-2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Plastic/Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
5. Global Prefilled Syringes Market, By Drug Type, 2025-2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
- Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Flush Saline Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
6. Global Prefilled Syringes Market, By Design, 2025 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Single-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Dual-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Multi-chambered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
7. Global Prefilled Syringes Market, By Product Type, 2025 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Staked in-needle pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Needle-free pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
8. Global Prefilled Syringes Market, By Usability, 2025 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
9. Global Prefilled Syringes Market, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Captive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Merchant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
10. Global Prefilled Syringes Market, By End User, 2025 - 2032, (US$ Billion
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
11. Global Prefilled Syringes Market, By Region, 2025 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2025 - 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
12. Competitive Landscape
- Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- West Pharmaceutical Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nipro Europe Group Companies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B.Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Polymedicure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amsino International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Leeford Healthcare Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL-Millennium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stevanato Group S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
13. Section
- Research Methodology
- About Us
샘플 요청 목록